In this study, we are trying to figure out how much of the anti-cancer drug SNDX-5613 works best with regular chemotherapy for treating a type of leukemia called acute myeloid leukemia. We are also looking at how this drug reacts with certain genes (NPM1 and MLL) to help us pick the right dose for treating patients in the future.
At each visit, you will meet with a member of the study team and fill out questionnaires. The study also involves blood draws, EKG (as instructed by doctor), bone marrow collection, and the willingness to take the study medication regularly.
Lineberger Comprehensive Cancer Center
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA
Joshua Zeidner
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Leukemia)
24-0430
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
